Medicinal clays improve the endurance of loaded inspiratory muscles in COPD: A randomized clinical trial of nonpharmacological treatment

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 2235-2248

  Baldi, Simonetta ^a   Pinna, Gian Domenico ^a   Bruschi, Claudio ^a   Caldara, Fabrizio ^b   Maestri, Roberto ^a   Dacosto, Elena ^a   Rezzani, Antonella ^a   Popovich, Ermanno ^a   Bellinzona, Ezio ^a   Crotti, Paola ^a   Montemartini, Silvia ^a   Fracchia, Claudio ^a  

^a IRCCS   (Italy)

^b Center of Thermal Studies Pietro d Abano   (Italy)

Author keywords

Balneotherapy; Cytokine IL 6; Hydrotherapy; Inspiratory resistive breathing; Pulmonary rehabilitation

Indexed keywords

INTERLEUKIN 6; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLAY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EFFECT SIZE; FEMALE; FORCED VITAL CAPACITY; HUMAN; LEISURE THERMAL ACTIVITY; LUNG FUNCTION TEST; MALE; MAXIMUM INSPIRATORY PRESSURE; MEDICINAL CLAY; MUD THERAPY; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PARALLEL DESIGN; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT PARAMETERS; SPA TREATMENT; SPIROMETRY; VENOUS BLOOD; ADAPTATION; BLOOD; CONVALESCENCE; ENDURANCE; INHALATION; ITALY; MIDDLE AGED; MUSCLE STRENGTH; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME;

ADAPTATION, PHYSIOLOGICAL; ADULT; AGED; BIOMARKERS; FEMALE; HUMANS; INHALATION; INTERLEUKIN-6; ITALY; MALE; MIDDLE AGED; MUD THERAPY; MUSCLE STRENGTH; PHYSICAL ENDURANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECOVERY OF FUNCTION; RESPIRATORY MUSCLES; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84945904261     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S87999     Document Type: Article

References (36)

1. Bellometti S, Galzigna L, Richelmi P, Gregotti C, Bertè F. Both serum receptors of tumor necrosis factor are influenced by mud pack treatment in osteoarthritis patients. Int J Tissue React. 2002;24(2):57-64.
2. Bellometti S, Richelmi P, Tassoni T, Bertè F. Production of matrix metalloproteinase and their inhibitors in osteoarthritic patients undergoing mud bath therapy. Int J Clin Pharmacol Res. 2005;25(2):77-94.
3. Bender T, Bariska J, Vághy R, Gomez R, Kovács I. Effect of balneo-therapy on the antioxidant system-a controlled pilot trial. Arch Med Res. 2007;38(1):86-89.
4. Costantino M, Giuberti G, Caraglia M, et al. Possible anti-oxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. Amino Acids. 2009;36(2):161-165.
5. Pellegrini M, Fanin D, Nowicki Y, et al. Effect of inhalation of thermal water on airway inflammation in chronic obstructive pulmonary disease. Respir Med. 2005;99(6):748-754.
6. Guarnieri G, Ferrazzoni S, Scarpa MC, Lalli A, Maestrelli P. Effects of inhalation of thermal water on exhaled breath condensate. Respiration. 2010;79(3):216-221.
7. Bishop D. Warm up I. Potential mechanisms and the effects of passive warm up on exercise performance. Sports Med. 2003;33(6): 439-454.
8. Galzaniga L, Moretto C, Lalli A. Physical and biochemical changes of thermal mud after maturation. Biomed Pharmacother. 1996;50(6-7):306-308.
9. Vernooy JH, Küçükaycan M, Jacobs JA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med. 2002;166(9):1218-1224.
10. Godoy I, Campana AO, Geraldo RR, Padovani CR, Paiva SA. Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients. Eur Respir J. 2003;22(6):920-925.
11. Koechlin C, Couillard A, Cristol JP, et al. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? Eur Respir J. 2004;23(4):538-544.
12. Vassilakopoulos T, Zakynthinos S, Roussos C. Strenuous resistive breathing induces pro-inflammatory cytokines and stimulates the HPA axis in humans. Am J Physiol. 1999;277(4 pt 2):R1013-R1019. Erratum in: Am J Physiol. 1999;277(6 Pt 2):Preceding 1541.
13. Vassilakopoulos T, Hussain SN. Ventilatory muscle activation and inflammation: cytokines, reactive oxygen species, and nitric oxide. J Appl Physiol. 2007;102(4):1687-1695.
14. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Gold executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
15. Quanjer PH, Tammeling GJ, Cotes JE, et al. Standardized lung function testing. Eur Respir J. 1993;6(3):5-40.
16. Black LF, Hyatt RE. Maximal static respiratory pressures: normal value and its relationship to age and sex. Am Rev Respir Dis. 1969;99(5):696-702.
17. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine Geneva WHO/EDM/TRM/2000. 1, Page 9. WHO, Guidelines on Developing Consumer Information on Proper Use of Traditional, Complementary and Alternative Medicine. Geneva: WHO; 2004. Available from: http://apps.who.int/medicinedocs/en/d/Js5525e/v
18. Fuster A, Sauleda J, Sala E, et al. Systemic inflammation after inspiratory loading in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3(1):149-153.
19. Martyn JB, Moreno RH, Paré PD, Pardy RL. Measurement of inspiratory muscle performance with incremental threshold loading. Am Rev Respir Dis. 1987;135(4):919-923.
20. Iranmanesh A, Rochester DF, Liu J, Veldhuis JD. Impaired adrenergic-and corticotrophic-axis outflow during exercise in chronic obstructive pulmonary disease. Metabolism. 2011;60(11):1521-1529.
21. Holloszy JO. Biochemical adaptation in muscles. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem. 1967;242(9):2278-2282.
22. Morgan TE, Cobb LA, Short FA, Ross R, Gunn DR. Effect of long term exercise on human muscle mitochondria. In: Pernow B, Saltin B, editors. Muscle Metabolism During Exercise. New York: Plenum; 1971:87-95.
23. Orozco-Levi M, Gea J, Lloreta JL, et al. Sub cellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J. 1999;13(2):371-378.
24. Ribera F, N'Guessan B, Zoll J, et al. Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(6):873-879.
25. Zoll J, Sanchez H, N'Guessan B, et al. Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle. J Physiol. 2002;543(pt-1):191-200.
26. Brooks GA, Hittelman KJ, Faulkner JA, Beyer R. Temperature, skeletal muscle mitochondrial functions, and oxygen debt. Am J Physiol. 1971;220(4):1053-1059.
27. Power A, Pearson N, Pham T, Cheung C, Phillips A, Hickey A. Uncoupling of oxidative phosphorylation and ATP synthase reversal within the hyper-thermic heart. Physiol Rep. 2014;2(9):e12138.
28. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Pedersen BK. Production of interleukin 6 in contracting human skeletal muscles can account for the exercise induced increase in plasma IL-6. J Physiol. 2000;29:237-242.
29. Pedersen BK, Steensberg A, Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol. 2001;536(pt 2):329-337.
30. Blank S, Chen V, Ianuzzo CD. Biochemical characteristics of mammalian diaphragms. Respir Physiol. 1988;74(1):115-125.
31. Raux M, Straus C, Redolfi S, et al. Electroencephalographic evidence for pre-motor cortex activation during inspiratory loading in humans. J Physiol. 2007;578(pt 2):569-578.
32. Paulus MP, Flagan T, Simmons AN, et al. Subjecting elite athletes to inspiratory breathing load reveals behavioral and neural signatures of optimal performers in extreme environments. PLoS One. 2012;7(1):e29394.
33. Boutron I, Guittet L, Estellat C, Moher D, Hróbjartsson A, Ravaud P. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med. 2007;4(2):e61.
34. Boutron I, Tubach F, Giraudeau B, Ravaud P. Blinding was judged more difficult to achieve and maintain in non-pharmacologic than pharmacologic trials. J Clin Epidemiol. 2004;57(6):543-550.
35. Devereaux PJ, Bhandari M, Clarke M, et al. Need for expertise based randomised controlled trials. BMJ. 2005;330(7482):88.
36. FEMTEC FoRST. HydroGlobe-Definition of a Global Framework for Hydrotherapy (A FEMTEC-FoRST Joint Project with the Cooperation of ISMH and the Technical Support of WHO); 2013. Available from: http://www.ismh-direct.net/dokumentumok.aspx?Ord=1. Accessed September 17, 2013.